Publications

Ylenia D'elia, Tim Whitfield, Marco Schlosser, Antoine Lutz, Thorsten Barnhofer, Gaël Chételat, Natalie L. Marchant, Julie Gonneaud, Olga Klimecki, The Medit-Ageing group. Impact of mindfulness-based and health self-management interventions on mindfulness, self-compassion, and physical activity in older adults with subjective cognitive decline: A secondary analysis of the SCD-Well randomized controlled trial. 2024. Alzheimer's & dementia (Amsterdam, Netherlands). 16. e12558.

Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Trial of Lixisenatide in Early Parkinson’s Disease. 2024. The New England Journal of Medicine. 390. 1176-1185.

Aurélie Wiedemann, Edouard Lhomme, Mélanie Huchon, Emile Foucat, Marion Bérerd-Camara, Lydia Guillaumat, Marcel Yaradouno, Jacqueline Tambalou, Cécile Rodrigues, Alexandre Ribeiro, Abdoul Habib Béavogui, Christine Lacabaratz, Rodolphe Thiébaut, Laura Richert, Yves Lévy & the Prevac study team. Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases. 2024. Nature Communications. 15. 7666.

Erhard N, Frison E, Asselineau J, Aouar B, Boveda S, Cochet H, Deisenhofer I, Deneke T, Gimbert A, Kautzner J, Knecht S, Maury P, Neuzil P, Rousset M, Scherr D, Schneider CW, Sermesant M, Wichterle D, Jaïs P; BEAT-AF Study group. Comparing pulsed field electroporation and radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: design and rationale of the BEAT PAROX-AF randomized clinical trial. 2024. Europace. 26. euae103.

Hamaker ME, Wildiers H, Ardito V, Arsandaux J, Barthod-Malat A, Davies P, Degol L, Ferrara L, Fourrier C, Kenis C, Kret M, Lalet C, Pelissier SM, O'Hanlon S, Rostoft S, Seghers N, Saillour-Glénisson F, Staines A, Schwimmer C, Thevenet V, Wallet C, Soubeyran P. Study protocol for two stepped-wedge interventional trials evaluating the effects of holistic information technology-based patient-oriented management in older multimorbid patients with cancer: The GERONTE trials. 2024. Journal of Geriatric Oncology. 15. 101761.

Andrew W Lee, Ken Liu, Edouard Lhomme, Julie Blie, John McCullough, Matthew T Onorato, Laurie Connor, Jakub K Simon, Sheri Dubey, Susan VanRheenen, Jonathan Deutsch, Abigail Owens, Amy Morgan, Carolee Welebob, Donna Hyatt, Sunita Nair, Benjamin Hamzé, Oumar Guindo, Samba O Sow, Abdoul H Beavogui, Bailah Leigh, Mohamed Samai, Pauline Akoo, Alimamy Serry-Bangura, Suzanne Fleck, Fatou Secka, Brett Lowe, Deborah Watson-Jones, Céline Roy, Lisa E Hensley, Mark Kieh, Beth-Ann G Coller, the PREVAC Study Team. Immunogenicity and vaccine shedding after 1 or 2 doses of rVZVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®): Results from a phase 2, randomized, placebo-controlled trial in children and adults. 2023. Clinical Infectious Diseases. 78. 870-879.

Edward Man-Lik Choi, Boris Lacarra, Muhammed O Afolabi, Boni Maxime Ale, Frank Baiden, Christine Bétard, Julie Foster, Benjamin Hamzé, Christine Schwimmer, Daniela Manno, Eric D'Ortenzio, David Ishola, Cheick Mohamed Keita, Babajide Keshinro, Yusupha Njie, Wim van Dijck, Auguste Gaddah, Dickson Anumendem, Brett Lowe, Renaud Vatrinet, Bolarinde Joseph Lawal, Godfrey T Otieno, Mohamed Samai, Gibrilla Fadlu Deen, Ibrahim Bob Swaray, Abu Bakarr Kamara, Michael Morlai Kamara, Mame Aminata Diagne, Dickens Kowuor, Chelsea McLean, Bailah Leigh, Abdoul Habib Beavogui, Maarten Leyssen, Kerstin Luhn, Cynthia Robinson, Macaya Douoguih, Brian Greenwood, Rodolphe Thiébaut, Deborah Watson-Jones ; EBOVAC-3/EBL2005 Study Team. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone. 2023. The Lancet Global Health. 11. e1743-e1752.

Ciani O, Manyara AM, Davies P, Stewart D, Weir CJ, Young AE, Blazeby J, Butcher NJ, Bujkiewicz S, Chan AW, Dawoud D, Offringa M, Ouwens M, Hróbjartssson A, Amstutz A, Bertolaccini L, Bruno VD, Devane D, Faria CDCM, Gilbert PB, Harris R, Lassere M, Marinelli L, Markham S, Powers JH, Rezaei Y, Richert L, Schwendicke F, Tereshchenko LG, Thoma A, Turan A, Worrall A, Christensen R, Collins GS, Ross JS, Taylor RS. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials. 2023. eClinicalMedicine. 65. 102283.

Tim Whitfield, Harriet Demnitz-King, Marco Schlosser, Thorsten Barnhofer, Eric Frison, Nina Coll-Padros, Sophie Dautricourt, Florence Requier, Marion Delarue, Julie Gonneaud, Olga M. Klimecki, Antoine Lutz, Léo Paly, Eric Salmon, Ann-Katrin Schild, Zuzana Walker, Frank Jessen, Gaël Chételat, Fabienne Collette, Miranka Wirth, Natalie L. Marchant & The Medit-Ageing Research Group. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. 2022. Alzheimers Research Therapy. 14. 1010-1016.